Landec Corporation to Present at the 22nd Annual ICR Conference

SANTA MARIA, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Curation Foods, Inc. and Lifecore Biomedical, Inc., announced today that Dr. Albert Bolles, the Company’s president and chief executive officer, and Brian McLaughlin, interim chief financial officer, will be presenting at the 22nd Annual ICR Conference, to be held January 13-15, 2020, at the Grande Lakes Orlando Resort in Florida.  

The Landec investor presentation is scheduled for Monday, January 13, 2020, at 9:30AM ET and can be accessed via webcast and hosted at the “Events & Presentations” section of the Company’s investor relations website:

About Landec Corporation
Landec Corporation (Nasdaq: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.  Landec designs, develops, manufactures, and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products, and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile, injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and medical device companies across multiple therapeutic categories to bring their innovations to market. For more information about the Company, visit Landec’s website at

Contact Information:
Investor Relations:
Jeff Sonnek
(646) 277-1263
[email protected]

Comments are closed.

Free newsletter for stock pics, interview transcripts & investing ideas